Podoplanin Expression in Canine Melanoma.

about

Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin

P2860

Q58568945-26A35DCC-A4FF-401B-B7E2-46F6DB63E723

P2860

Podoplanin Expression in Canine Melanoma.

Item

http://www.wikidata.org/entity/Q40546654

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Podoplanin Expression in Canine Melanoma.

@en

type

Item

label

Podoplanin Expression in Canine Melanoma.

@en

prefLabel

Podoplanin Expression in Canine Melanoma.

@en

P1476

Podoplanin Expression in Canine Melanoma

@en

P2093

Mika K Kaneko

http://www.w3.org/2001/XMLSchema#string

Ryusuke Honma

http://www.w3.org/2001/XMLSchema#string

Satoru Konnai

http://www.w3.org/2001/XMLSchema#string

Satoshi Ogasawara

http://www.w3.org/2001/XMLSchema#string

Yuki Fujii

http://www.w3.org/2001/XMLSchema#string

Yumiko Kagawa

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors

Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas

Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis

A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin.

Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas

Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling

Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma.

Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.

Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity.

P304

304-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/MAB.2016.0040

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yukinari Kato

P577

2016-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27918691

http://www.w3.org/2001/XMLSchema#string

P932

5206701

http://www.w3.org/2001/XMLSchema#string

Podoplanin Expression in Canine Melanoma.

about

P2860

P2860

Podoplanin Expression in Canine Melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932